Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep;36(9):1613-1620.
doi: 10.1007/s10096-017-2974-z. Epub 2017 Apr 8.

Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992-2013

Affiliations

Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992-2013

U Naseer et al. Eur J Clin Microbiol Infect Dis. 2017 Sep.

Abstract

Shiga toxin-producing Escherichia coli (STEC) may cause haemolytic uraemic syndrome (HUS). Age ≤5 years and presence of stx2a and eae are risk factors for the development of HUS. In this study, we investigated STEC isolates for the presence of adhesins, toxins and molecular risk assessment (MRA) factors to identify virulence genes associated with HUS development. We included non-duplicate isolates from all STEC infections (n = 340, HUS = 32) reported to the Norwegian National Reference Laboratory (NRL) for Enteropathogenic Bacteria from 1992 to 2013. The most common STEC were O157:H7/H- (34%) and O103:H2 (14%). We retrospectively screened the isolates by three multiplex polymerase chain reactions (PCRs) for adhesins (n = 11), toxins (n = 5) and MRA (n = 15). We calculated odds ratios (ORs) and adjusted odds ratios (aORs) for associations with HUS development. On average, isolates were positive for 15 virulence genes (range: 1-24); two toxins (range: 0-4), five adhesins (range: 0-8) and eight MRA genes (range: 0-13). The gene combinations were clustered within serotypes. Isolates from HUS cases were positive for eae and IpfA O26, and negative for saa, eibG, astA, cnf, subA and pic. We identified 11 virulence genes with a significant association to HUS development. Multivariable analyses adjusted for age group and Shiga toxin identified nleH1-2 [aOR 8.4, 95% confidence interval (CI); 2.18-32.3] as an independent risk factor for the development of HUS from an STEC infection. This study demonstrated that the non-LEE effector protein nleH1-2 may be an important predictor for elevated risk of developing HUS from STEC infections. We recommend the NRL for Enteropathogenic Bacteria to consider including nleH1-2 screening as part of routine STEC surveillance.

Keywords: Haemolytic Uraemic Syndrome; Positive Predictive Value; Shiga Toxin; Toxin Gene; Virulence Gene.

PubMed Disclaimer

Conflict of interest statement

Funding

This study was funded by the Norwegian Institute of Public Health.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

For this type of study, formal consent is not required.

Informed consent

No identifying information is included

Figures

Fig. 1
Fig. 1
Unweighted pair group method with arithmetic mean (UPGMA) phylogenetic estimation of the relatedness of Shiga toxin-producing Escherichia coli (STEC) isolates (n = 340) based on the absence or presence of 33 virulence genes and subtypes of stx1 and stx2. Phylogeny constructed using the majority summary method with 200 sample permutations. Branch intensity is according to descending resampling support (light–dark). Global cophenetic correlation was estimated to be 94%. Each node represents a unique combination of virulence genes, with the size of the node correlating to the number of isolates with that combination. Major serotypes are coloured according to the legend. Isolates from cases developing haemolytic uraemic syndrome (HUS) are indicated on the figure

References

    1. Smith JL, Fratamico PM, Gunther NW., 4th Shiga toxin-producing Escherichia coli. Adv Appl Microbiol. 2014;86:145–197. doi: 10.1016/B978-0-12-800262-9.00003-2. - DOI - PubMed
    1. Bryan A, Youngster I, McAdam AJ. Shiga toxin producing Escherichia coli. Clin Lab Med. 2015;35(2):247–272. doi: 10.1016/j.cll.2015.02.004. - DOI - PubMed
    1. Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med. 1995;333(6):364–368. doi: 10.1056/NEJM199508103330608. - DOI - PubMed
    1. Persson S, Olsen KEP, Ethelberg S, Scheutz F. Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J Clin Microbiol. 2007;45(6):2020–2024. doi: 10.1128/JCM.02591-06. - DOI - PMC - PubMed
    1. Brandal LT, Wester AL, Lange H, Løbersli I, Lindstedt BA, Vold L, Kapperud G. Shiga toxin-producing Escherichia coli infections in Norway, 1992–2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome. BMC Infect Dis. 2015;15:324. doi: 10.1186/s12879-015-1017-6. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources